Critical care of patients with paediatric valvar cardiac disease

Cardiol Young. 2014 Dec;24(6):1071-6. doi: 10.1017/S1047951114002169.

Abstract

Valvar cardiac disease accounts for a large percentage of heart lesions in the paediatric population. There are a variety of congenital and acquired valvar lesions produced by different mechanisms that produce unique physiologies. With the development of more advanced cardiac interventional procedures and congenital cardiac surgery techniques, most of these lesions can be repaired in a single or multi-stage approach. Given the potential for significant symptomatology before intervention, it is imperative to review the critical care management of paediatric valvar heart disease. The purpose of this article is to provide an overview of the current critical care management of valvar cardiac disease. We approach each cardiac valve individually in order to review the pathophysiology caused by valve dysfunction (obstruction and incompetence) and elaborate on the most frequent diagnoses, specific cardiac physiology, potential for other organ system associations, and perioperative management.

Keywords: and pulmonary regurgitation.

Publication types

  • Review

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use*
  • Cardiotonic Agents / therapeutic use*
  • Critical Care / methods*
  • Diuretics / therapeutic use*
  • Heart Valve Diseases / congenital
  • Heart Valve Diseases / therapy*
  • Heart Valve Prosthesis Implantation*
  • Humans
  • Infant
  • Infant, Newborn

Substances

  • Anti-Arrhythmia Agents
  • Cardiotonic Agents
  • Diuretics